These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23400852)

  • 1. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
    Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
    Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
    Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
    DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
    Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
    Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
    Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
    Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
    Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
    Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.
    Pajtler KW; Mahlow E; Odersky A; Lindner S; Stephan H; Bendix I; Eggert A; Schramm A; Schulte JH
    Oncotarget; 2014 Nov; 5(22):11180-92. PubMed ID: 25361003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
    Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
    Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
    Kim CJ; Matsuo T; Lee KH; Thiele CJ
    Am J Pathol; 1999 Nov; 155(5):1661-70. PubMed ID: 10550322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
    Rickard S; Ono SJ
    Exp Mol Pathol; 2008 Dec; 85(3):147-54. PubMed ID: 18952077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
    Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
    Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma].
    Lebedev TD; Spirin PV; Suntsova MV; Ivanova AV; Buzdin AA; Prokofjeva MM; Rubtsov PM; Prassolov VS
    Mol Biol (Mosk); 2015; 49(6):1052-5. PubMed ID: 26710790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A; Ikegaki N; Liu XG; Brodeur GM
    Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.
    Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
    Med Pediatr Oncol; 2000 Dec; 35(6):569-72. PubMed ID: 11107119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotary bioreactor culture can discern specific behavior phenotypes in Trk-null and Trk-expressing neuroblastoma cell lines.
    Redden RA; Iyer R; Brodeur GM; Doolin EJ
    In Vitro Cell Dev Biol Anim; 2014 Mar; 50(3):188-93. PubMed ID: 24477561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of TrkA protein expression by miRNA‑92a promotes the proliferation and migration of human neuroblastoma cells.
    Liao W; Zhang H; Feng C; Wang T; Zhang Y; Tang S
    Mol Med Rep; 2014 Aug; 10(2):778-84. PubMed ID: 24839961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
    Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
    Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
    Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
    Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
    Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
    Kim CJ; Chi JG; Thiele CJ
    Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.